Chris joined Ei in 2016 having previously worked for eight years as a Scientist/Manager for Boehringer Ingelheim in an Analytical R&D role for both drug substances and drug products. His work at BI was centered around analytical development and validation of a wide variety of analytical techniqes. He managed the Launch Analytics group which was responsible for ensuring methods were ready and available for QC use after product commercialization. He was also involved with conducting research in identifying impurities for various drug substances and drug products. Prior to his tenure at BI, Chris worked as a development/validation scientist with Alpharma in support of getting generic drug products to market. Chris received his B.S.and M.S. in Chemistry from the University of North Carolina at Wilmington in 1992 and 1995, respectively.
150 N. Research Campus Dr.
Kannapolis, NC 28081